#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant melanoma VEXAS syndrome Malignant peritoneal neoplasm Chronic myelomonocytic leukaemia Synovial sarcoma Dementia Alzheimer's type Small intestine leiomyosarcoma Cutaneous lupus erythematosus Choroidal dystrophy Measles Angiosarcoma Rett syndrome Congenital growth hormone deficiency Von Willebrand's disease Oesophageal carcinoma More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Basic Information Urea cycle disorder – Basic Information Urea cycle disorder – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease Pulmonary sarcoidosis – Diagnostics Primary immunodeficiency syndrome – Life with Disease Sarcoma Idiopathic inflammatory myopathy – Diagnostics KBG syndrome – Treatment Systemic mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Albumin PEGVISOMANT Pimecrolimus Tinzaparin Sodium Sulfonamides, Urea Derivatives IHMA-2121771-2 IDOR-1117-2520C Clemastine Pilocarpine Hydrochloride Valganciclovir Hydrochloride LUMC-BOB1-B7-TCR.1 Amivantamab GSKVX000000034792 Antithymocyte Immunoglobulin Abacavir Sulfate Atorvastatin Calcium Cannabis Sativa Flower Levosimendan Miransertib Bay 3283142 More therapies…

    Learn about Your Condition

    Malignant fibrous histiocytoma Mucopolysaccharidosis III Erectile dysfunction Perinatal depression Rhabdomyosarcoma recurrent Dyspnoea Endocarditis bacterial Nasal sinus cancer Immune-mediated enterocolitis Infertility Hereditary angioedema Autoimmune disorder Dyspepsia Mantle cell lymphoma stage IV Pseudoxanthoma elasticum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. General Hospital of Elefsina “Thriassio”

General Hospital of Elefsina “Thriassio”

G. Gennimata Ave, Magoula, 19018, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!